NP / PA
Dimitri, Almas
Dimitri, Almas was paid $8K by Medicaid between Aug 2022 and Jan 2023, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoDIMITRI, ALMAS
SOUTHBOROUGH, MA 01772
SOUTHBOROUGH, MA 01772
33aNPI1497082853assigned 11/05/2009
33bProvider typePediatric Nurse Practitioner
28Total paid$8K
24GClaims223
24DCodes billed7
24AFirst – last monthAug 2022 – Jan 2023
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Massachusetts
Rank by total paid#48 of 125
Median peer was paid$6K
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 210 | $7K | |
| 2023 | 13 | $759.33 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 71 | 70 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 12 | 12 | $1K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.8% | 14 | 14 | $715.75 |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 7.9% | 71 | 70 | $642.55 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.6% | 12 | 12 | $615.72 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.3% | 15 | 15 | $351.90 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.5% | 28 | 27 | $287.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.